Nicholas Sajjadi to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Nicholas Sajjadi has written about Diabetes Mellitus, Type 2.
Connection Strength
0.151
-
Discontinuation and non-publication rates of U.S. clinical trials for the pharmacologic treatment of type 2 diabetes mellitus: A cross-sectional analysis. Diabetes Metab. 2022 Mar; 48(2):101317.
Score: 0.151